AngioDynamics, Inc. (ANGO) Reaches $15.55 After 8.00% Down Move; Mirador Capital Partners LP Increased Bristol Myers Squibb Co (BMY) Position

July 18, 2017 - By Maria Brooks

The stock of AngioDynamics, Inc. (NASDAQ:ANGO) is a huge mover today! About 78,697 shares traded. AngioDynamics, Inc. (NASDAQ:ANGO) has risen 31.47% since July 18, 2016 and is uptrending. It has outperformed by 14.77% the S&P500.The move comes after 6 months negative chart setup for the $580.29 million company. It was reported on Jul, 18 by Barchart.com. We have $14.31 PT which if reached, will make NASDAQ:ANGO worth $46.42 million less.

Mirador Capital Partners Lp increased Bristol Myers Squibb Co (BMY) stake by 42.86% reported in 2016Q4 SEC filing. Mirador Capital Partners Lp acquired 14,618 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Mirador Capital Partners Lp holds 48,725 shares with $2.85 million value, up from 34,107 last quarter. Bristol Myers Squibb Co now has $89.23 billion valuation. The stock declined 0.47% or $0.26 reaching $54.52 on the news. About 792,559 shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since July 18, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Investors sentiment increased to 3.16 in Q4 2016. Its up 0.55, from 2.61 in 2016Q3. It improved, as 8 investors sold AngioDynamics, Inc. shares while 23 reduced holdings. 32 funds opened positions while 66 raised stakes. 61.14 million shares or 119.62% more from 27.84 million shares in 2016Q3 were reported. Comerica Bankshares owns 33,243 shares for 0% of their portfolio. Ameriprise Financial Incorporated holds 0% or 502,028 shares in its portfolio. Numeric Investors Ltd holds 827,439 shares or 0.15% of its portfolio. Boothbay Fund Mgmt Ltd Company accumulated 13,794 shares. Mckinley Mgmt Llc Delaware reported 0% stake. Cubist Systematic Strategies Lc holds 20,210 shares or 0.03% of its portfolio. Amer Century Companies owns 179,409 shares. Spark Mgmt Ltd invested 0.19% in AngioDynamics, Inc. (NASDAQ:ANGO). Panagora Asset Mgmt Inc holds 0.02% or 217,289 shares in its portfolio. 91 are owned by Mufg Americas. First Quadrant L P Ca invested in 0.04% or 106,151 shares. Profund Limited Liability Company owns 10,060 shares or 0.01% of their US portfolio. Cornerstone Cap Management Holding Limited Liability holds 259,800 shares or 0.03% of its portfolio. Secor Cap Advisors Lp has invested 0.08% in AngioDynamics, Inc. (NASDAQ:ANGO). Blackrock Institutional Trust Co Na invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO).

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The company has market cap of $580.29 million. The Company’s devices are used in minimally invasive, image-guided procedures. It currently has negative earnings. The Firm offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery.

Among 7 analysts covering AngioDynamics (NASDAQ:ANGO), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. AngioDynamics had 11 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of AngioDynamics, Inc. (NASDAQ:ANGO) has “Hold” rating given on Monday, July 10 by Canaccord Genuity. On Friday, January 8 the stock rating was maintained by Canaccord Genuity with “Buy”. Sidoti initiated the stock with “Neutral” rating in Wednesday, September 23 report. The stock of AngioDynamics, Inc. (NASDAQ:ANGO) earned “Hold” rating by Canaccord Genuity on Wednesday, May 31. As per Tuesday, April 5, the company rating was downgraded by Canaccord Genuity. KeyBanc Capital Markets initiated the stock with “Overweight” rating in Friday, July 24 report. The firm earned “Equal Weight” rating on Wednesday, February 8 by Barclays Capital. The rating was reinitiated by Piper Jaffray with “Neutral” on Friday, April 8. The firm has “Buy” rating given on Friday, November 4 by Cantor Fitzgerald. Zacks upgraded the shares of ANGO in report on Monday, August 31 to “Sell” rating.

Since February 27, 2017, it had 1 insider purchase, and 6 insider sales for $9.91 million activity. 8,096 shares valued at $463,779 were sold by Caldarella Joseph C on Wednesday, March 15. The insider LEUNG SANDRA sold 92,405 shares worth $5.27M. 5,000 shares valued at $282,470 were sold by Schmukler Louis S on Friday, March 17. ANDREOTTI LAMBERTO had sold 34,000 shares worth $1.91 million. 12,000 Bristol-Myers Squibb Co (NYSE:BMY) shares with value of $681,240 were bought by Samuels Theodore R. II.